Video
Barbara Jobst, MD
Publish date: May 4, 2017
At AAN 2017, Dr. Jobst describes the effectiveness of responsive neurostimulation for medically intractable epilepsy.
Related Articles
Conference Coverage
-
Noninvasive testing in midlife flags late-onset epilepsy risk Publish date: April 27, 2023 -
Novel neural cell therapy: A cure for focal epilepsy? Publish date: April 24, 2023 -
Seizures in dementia hasten decline and death Publish date: December 14, 2022 -
Three antiseizure medications join list for newborn risks Publish date: December 13, 2022 -
‘Striking’ rate of mental health comorbidities in epilepsy Publish date: December 12, 2022 -
Significant racial disparities persist in status epilepticus Publish date: December 12, 2022 -
Study implicates myelin plasticity in absence seizures Publish date: December 9, 2022 -
Newer brand-name drugs fuel spending on antiseizure medications -
Diazepam nasal spray effective in Lennox-Gastaut syndrome Publish date: October 24, 2022 -
Antiseizure medication appears safe in pregnancy
Multimedia
-
Patients describe significant impact of epilepsy on their lives -
Tatiana Falcone, MD Publish date: December 18, 2017 -
Andrew G. Herzog, MD Publish date: December 18, 2017
Literature Review
-
RNA therapeutics will ‘change everything’ in epilepsy Publish date: November 8, 2023 -
Minorities with epilepsy blocked from receiving ‘highest quality of care’ -
Modified Atkins diet beneficial in drug-resistant epilepsy -
Antiepileptic drugs tied to increased Parkinson’s disease risk -
Strong two-way link between epilepsy and depression Publish date: December 6, 2022 -
High drug costs exclude most neurology patients from cutting-edge treatment -
Drug-resistant epilepsy needs earlier surgical referral -
‘Striking’ jump in cost of brand-name epilepsy meds -
Air pollution is a seizure trigger for patients with epilepsy -
New guidance on cannabis use for treatment-resistant epilepsy
Neurobehavioral comorbidities of epilepsy
Question 1 of 5